Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lipase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN113564144A discloses lipase mutants enabling room temperature, water-phase asymmetric hydrolysis with >95% e.e., offering cost-effective pharmaceutical intermediate manufacturing.
Patent CN119432807B reveals high-activity lipase mutant for epoxide production offering mild conditions and scalable supply chain solutions for global buyers.